AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
CIRRHOTICS CAN BE TREATED SUCCESSFULLY WITH HIGH-DOSE (5 MU DAILY) INTERFERON
Authors: VANTHIEL DH FRIEDLANDER L MOLLOY PJ KANIA RJ
Citation: Dh. Vanthiel et al., CIRRHOTICS CAN BE TREATED SUCCESSFULLY WITH HIGH-DOSE (5 MU DAILY) INTERFERON, Hepatology, 28(4), 1998, pp. 281-281
ASSESSMENT OF THE RISK INHERENT WITH THE UTILIZATION OF HBCAB POSITIVE DONOR ORGANS
Authors: VANTHIEL DH FRIEDLANDER L KANIA RJ MOLLOU PJ FARUKI H
Citation: Dh. Vanthiel et al., ASSESSMENT OF THE RISK INHERENT WITH THE UTILIZATION OF HBCAB POSITIVE DONOR ORGANS, Hepatology, 28(4), 1998, pp. 739-739
INDIVIDUALS WITH SERIOUS PSYCHIATRIC DISEASE CAN BE TREATED SUCCESSFULLY WITH IFN
Authors: VANTHIEL DH FRIEDLANDER L MOLLOY PJ KANIA RJ
Citation: Dh. Vanthiel et al., INDIVIDUALS WITH SERIOUS PSYCHIATRIC DISEASE CAN BE TREATED SUCCESSFULLY WITH IFN, Hepatology, 28(4), 1998, pp. 1640-1640
HIGH DAILY DOSE (10 MU) INTERFERON-A (IFN) THERAPY OF NONRESPONDERS TO 5 MU DAILY
Authors: VANTHIEL DH FRIEDLANDER L KANIA RJ MALLOY PJ
Citation: Dh. Vanthiel et al., HIGH DAILY DOSE (10 MU) INTERFERON-A (IFN) THERAPY OF NONRESPONDERS TO 5 MU DAILY, Hepatology, 28(4), 1998, pp. 2199-2199
TREATMENT OF CHRONIC HEPATITIS-C IN INDIVIDUALS WITH PREEXISTING OR CONFOUNDING NEUROPSYCHIATRIC DISEASE
Authors: VANTHIEL DH FRIEDLANDER L DEMARIA N MOLLOY PJ KANIA RJ COLANTONI A
Citation: Dh. Vanthiel et al., TREATMENT OF CHRONIC HEPATITIS-C IN INDIVIDUALS WITH PREEXISTING OR CONFOUNDING NEUROPSYCHIATRIC DISEASE, Hepato-gastroenterology, 45(20), 1998, pp. 328-330
A PRELIMINARY EXPERIENCE WITH GM-CSF PLUS INTERFERON IN PATIENTS WITHHBV AND HCV RESISTANT TO INTERFERON THERAPY
Authors: VANTHIEL DH FRIEDLANDER L KANIA RJ MOLLOY PJ HASSANEIN T FARUKI H
Citation: Dh. Vanthiel et al., A PRELIMINARY EXPERIENCE WITH GM-CSF PLUS INTERFERON IN PATIENTS WITHHBV AND HCV RESISTANT TO INTERFERON THERAPY, Journal of viral hepatitis, 4, 1997, pp. 101-106
DISAPPEARANCE OF HEPATITIS-C VIRUS IN THE LIVER AFTER IFN-TREATMENT IS ASSOCIATED WITH DOWN-REGULATED NF-KAPPA-B ACTIVATION AND IL-6 EXPRESSION
Authors: GAWECO AS KANIA RJ FRIEDLANDER L MITCHELL B CROSS P MOLLOY PJ VANTHIEL DH
Citation: As. Gaweco et al., DISAPPEARANCE OF HEPATITIS-C VIRUS IN THE LIVER AFTER IFN-TREATMENT IS ASSOCIATED WITH DOWN-REGULATED NF-KAPPA-B ACTIVATION AND IL-6 EXPRESSION, Hepatology, 26(4), 1997, pp. 724-724
INTERFERON TREATMENT OF CIRRHOTIC-PATIENTS - EXPERIENCE IN A PRIVATE-PRACTICE SETTING
Authors: KANIA RJ FRIEDLANDER L VANTHIEL DH MOLLOY PJ
Citation: Rj. Kania et al., INTERFERON TREATMENT OF CIRRHOTIC-PATIENTS - EXPERIENCE IN A PRIVATE-PRACTICE SETTING, Hepatology, 26(4), 1997, pp. 1625-1625
LAMIVUDINE PLUS INTERFERON FOR THE TREATMENT OF IFN NONRESPONSIVE CHRONIC HEPATITIS-C INFECTION
Authors: KANIA RJ FRIEDLANDER L VANTHIEL DH MOLLOY PJ
Citation: Rj. Kania et al., LAMIVUDINE PLUS INTERFERON FOR THE TREATMENT OF IFN NONRESPONSIVE CHRONIC HEPATITIS-C INFECTION, Hepatology, 26(4), 1997, pp. 1626-1626
EVIDENCE THAT 2.5 MU OF INTERFERON DAILY IS NOT SUFFICIENT TO SUPPRESS HCV REPLICATION
Authors: VANTHIEL DH FRIEDLANDER L KANIA RJ MOLLOY PJ
Citation: Dh. Vanthiel et al., EVIDENCE THAT 2.5 MU OF INTERFERON DAILY IS NOT SUFFICIENT TO SUPPRESS HCV REPLICATION, Hepatology, 26(4), 1997, pp. 1969-1969
LAMIVUDINE TREATMENT OF ADVANCED AND DECOMPENSATED LIVER-DISEASE DUE TO HEPATITIS-B
Authors: VANTHIEL DH FRIEDLANDER L KANIA RJ MOLLOY PJ HASSANEIN T WAHLSTROM E FARUKI H
Citation: Dh. Vanthiel et al., LAMIVUDINE TREATMENT OF ADVANCED AND DECOMPENSATED LIVER-DISEASE DUE TO HEPATITIS-B, Hepato-gastroenterology, 44(15), 1997, pp. 808-812
ATTITUDES TOWARD VS PERFORMANCE OF RECTAL EXAMS
Authors: LEFF DB AZZOUZ M MOLLOY PJ KANIA RJ
Citation: Db. Leff et al., ATTITUDES TOWARD VS PERFORMANCE OF RECTAL EXAMS, Gastroenterology, 112(4), 1997, pp. 25-25
RETREATMENT OF HEPATITIS-C INTERFERON NONRESPONDERS WITH LARGER DOSESOF INTERFERON WITH AND WITHOUT PHLEBOTOMY
Authors: VANTHIEL DH FRIEDLANDER L MOLLOY PJ KANIA RJ FAGIUOLI S WRIGHT HI GASBARRINI A CARACENI P
Citation: Dh. Vanthiel et al., RETREATMENT OF HEPATITIS-C INTERFERON NONRESPONDERS WITH LARGER DOSESOF INTERFERON WITH AND WITHOUT PHLEBOTOMY, Hepato-gastroenterology, 43(12), 1996, pp. 1557-1561
NEW APPROACH TO HCV TREATMENT - RECOGNITION OF DISEASE PROCESS AS SYSTEMIC VIRAL-INFECTION RATHER THAN AS LIVER-DISEASE
Authors: FRIEDLANDER L VANTHIEL DH FARUKI H MOLLOY PJ KANIA RJ HASSANEIN T
Citation: L. Friedlander et al., NEW APPROACH TO HCV TREATMENT - RECOGNITION OF DISEASE PROCESS AS SYSTEMIC VIRAL-INFECTION RATHER THAN AS LIVER-DISEASE, Digestive diseases and sciences, 41(8), 1996, pp. 1678-1681
SUCCESSFUL EMPIRIC TREATMENT OF HSV HEPATITIS IN PREGNANCY - CASE-REPORT AND REVIEW OF THE LITERATURE
Authors: GLORIOSO DV MOLLOY PJ VANTHIEL DH KANIA RJ
Citation: Dv. Glorioso et al., SUCCESSFUL EMPIRIC TREATMENT OF HSV HEPATITIS IN PREGNANCY - CASE-REPORT AND REVIEW OF THE LITERATURE, Digestive diseases and sciences, 41(6), 1996, pp. 1273-1275
TREATMENT OF HEPATITIS-C VIRUS IN ELDERLY PERSONS WITH INTERFERON-ALPHA
Authors: VANTHIEL DH FRIEDLANDER L CARACENI P MOLLOY PJ KANIA RJ
Citation: Dh. Vanthiel et al., TREATMENT OF HEPATITIS-C VIRUS IN ELDERLY PERSONS WITH INTERFERON-ALPHA, The journals of gerontology. Series A, Biological sciences and medical sciences, 50(6), 1995, pp. 330-333
INTERFERON-ALPHA CAN BE USED SUCCESSFULLY IN PATIENTS WITH HEPATITIS-C VIRUS-POSITIVE CHRONIC HEPATITIS WHO HAVE A PSYCHIATRIC-ILLNESS
Authors: VANTHIEL DH FRIEDLANDER L MOLLOY PJ FAGIUOLI S KANIA RJ CARACENI P
Citation: Dh. Vanthiel et al., INTERFERON-ALPHA CAN BE USED SUCCESSFULLY IN PATIENTS WITH HEPATITIS-C VIRUS-POSITIVE CHRONIC HEPATITIS WHO HAVE A PSYCHIATRIC-ILLNESS, European journal of gastroenterology & hepatology, 7(2), 1995, pp. 165-168
HCV GENOTYPE IN INTERFERON NONRESPONDERS TREATED FOR OVER ONE-YEAR
Authors: FARUKI H FRIEDLANDER L KANIA RJ MOLLOY PJ VANTHIEL DH
Citation: H. Faruki et al., HCV GENOTYPE IN INTERFERON NONRESPONDERS TREATED FOR OVER ONE-YEAR, Hepatology, 22(4), 1995, pp. 1236-1236
INTERFERON-ALPHA TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTS WITH EVIDENCE FOR COEXISTENT AUTOIMMUNE DYSREGULATION
Authors: VANTHIEL DH MOLLOY PJ FRIEDLANDER L KANIA RJ FAGIUOLI S CARACENI P WRIGHT HI ZUHDI N
Citation: Dh. Vanthiel et al., INTERFERON-ALPHA TREATMENT OF CHRONIC HEPATITIS-C IN PATIENTS WITH EVIDENCE FOR COEXISTENT AUTOIMMUNE DYSREGULATION, Hepato-gastroenterology, 42(6), 1995, pp. 900-906
COMBINATION TREATMENT OF ADVANCED HCV ASSOCIATED LIVER-DISEASE WITH INTERFERON AND G-CSF
Authors: VANTHIEL DH FARUKI H FRIEDLANDER L FAGIUOLI S CARACENI P MOLLOY PJ KANIA RJ WRIGHT HI
Citation: Dh. Vanthiel et al., COMBINATION TREATMENT OF ADVANCED HCV ASSOCIATED LIVER-DISEASE WITH INTERFERON AND G-CSF, Hepato-gastroenterology, 42(6), 1995, pp. 907-912
CHRONIC HEPATITIS-C IN PATIENTS WITH NORMAL OR NEAR NORMAL ALANINE AMINOTRANSFERASE LEVELS - THE ROLE OF INTERFERON-ALPHA-2B THERAPY
Authors: VANTHIEL DH CARACENI P MOLLOY PJ HASSANEIN T KANIA RJ GURAKAR A FRIEDLANDER L
Citation: Dh. Vanthiel et al., CHRONIC HEPATITIS-C IN PATIENTS WITH NORMAL OR NEAR NORMAL ALANINE AMINOTRANSFERASE LEVELS - THE ROLE OF INTERFERON-ALPHA-2B THERAPY, Journal of hepatology, 23(5), 1995, pp. 503-508
USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS
Authors: NAUM SM MOLLOY PJ KANIA RJ MCGARR J VANTHIEL DH
Citation: Sm. Naum et al., USE OF THALIDOMIDE IN TREATMENT AND MAINTENANCE OF IDIOPATHIC ESOPHAGEAL ULCERS IN HIV+ INDIVIDUALS, Digestive diseases and sciences, 40(5), 1995, pp. 1147-1148
ILEAL INTUSSUSCEPTION AND OBSTRUCTION AS PRESENTATION OF INFLAMMATORYFIBROID POLYP
Authors: BRADLEY B MOLLOY PJ GLICK K KANIA RJ
Citation: B. Bradley et al., ILEAL INTUSSUSCEPTION AND OBSTRUCTION AS PRESENTATION OF INFLAMMATORYFIBROID POLYP, Digestive diseases and sciences, 40(4), 1995, pp. 812-813
EVIDENCE THAT THE DURATION OF IFN THERAPY SHOULD BE TAILORED TO THE VIROLOGICAL RESPONSE TO TREATMENT USING MORE THAN ONE IN-VIVO RESERVOIROF INFECTION
Authors: VANTHIEL D FRIEDLANDER L HASSANEIN T GURAKAR A WRIGHT H MOLLOY PJ KANIA RJ FARUKI H
Citation: D. Vanthiel et al., EVIDENCE THAT THE DURATION OF IFN THERAPY SHOULD BE TAILORED TO THE VIROLOGICAL RESPONSE TO TREATMENT USING MORE THAN ONE IN-VIVO RESERVOIROF INFECTION, Gastroenterology, 108(4), 1995, pp. 1192-1192
THE USE OF GM-CSF PLUS IFN TO ACHIEVE BIOCHEMICAL AND VIROLOGICAL RESOLUTION OF CHRONIC HEPATITIS-C IN PRIOR IFN NONRESPONDERS
Authors: VANTHIEL DH MOLLOY PJ KANIA RJ HASSANEIN T FARUKI H FRIEDLANDER L
Citation: Dh. Vanthiel et al., THE USE OF GM-CSF PLUS IFN TO ACHIEVE BIOCHEMICAL AND VIROLOGICAL RESOLUTION OF CHRONIC HEPATITIS-C IN PRIOR IFN NONRESPONDERS, Gastroenterology, 108(4), 1995, pp. 1193-1193
Risultati: 1-25 | 26-31